PHI with Infectious Rhinitis
How does this condition affect your private health insurance?
Infektiöser Schnupfen, commonly known as the common cold, is a highly prevalent viral infection of the upper respiratory tract. It's primarily caused by rhinoviruses, though other viruses like coronaviruses and adenoviruses can also be responsible. Symptoms typically include a runny or stuffy nose, sneezing, sore throat, cough, and sometimes mild headache or low-grade fever. The infection spreads easily through airborne droplets and direct contact, making it widespread. While generally a mild and self-limiting illness, it can occasionally lead to secondary bacterial infections such as sinusitis or ear infections, especially in children or immunocompromised individuals.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Typically 7-10 days, though some symptoms may persist slightly longer.
Duration of Illness (Lifetime)
Recurrent acute events throughout a lifetime, as immunity is specific to the viral strain.
Cost of Treatment (Initial)
Low (e.g., 10-50 EUR for over-the-counter remedies).
Cost of Treatment (Lifetime)
Moderate, due to multiple recurrences and ongoing purchase of symptomatic relief medications (e.g., 100-500+ EUR).
Mortality Rate
Extremely low (<0.001%), primarily in very vulnerable populations due to severe complications.
Risk of Secondary Damages
Low to moderate (5-15%) for secondary bacterial infections (e.g., sinusitis, otitis media), especially in children or immunocompromised individuals.
Probability of Full Recovery
Very high (>99%) without long-term consequences.
Underlying Disease Risk
Low (<5%), as the common cold typically does not indicate a pre-existing underlying disease, although a weakened immune system can increase susceptibility.